Ikarian Capital LLC Sells 100,000 Shares of COMPASS Pathways plc
CMPS Stock | USD 4.75 0.30 6.74% |
Slightly above 55% of Compass Pathways' private investors are presently thinking to get in. The analysis of overall sentiment of trading Compass Pathways Plc stock suggests that some investors are interested at this time. Compass Pathways' investing sentiment can be driven by a variety of factors including economic data, Compass Pathways' earnings reports, geopolitical events, and overall market trends.
Compass |
Ikarian Capital LLC lessened its holdings in COMPASS Pathways plc by 33.0 percent during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 202,908 shares of the companys stock after selling 100,000 shares during the quarter. Ikarian Capital LLC owned approximately 0.30 percent of
Read at thelincolnianonline.com
Compass Pathways Fundamental Analysis
We analyze Compass Pathways' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compass Pathways using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compass Pathways based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Compass Pathways is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Compass Pathways Plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Compass Pathways stock to make a market-neutral strategy. Peer analysis of Compass Pathways could also be used in its relative valuation, which is a method of valuing Compass Pathways by comparing valuation metrics with similar companies.
Peers
Compass Pathways Related Equities
ACHC | Acadia Healthcare | 1.20 | ||||
ADUS | Addus HomeCare | 0.89 | ||||
AMED | Amedisys | 0.56 | ||||
FSNUY | Fresenius | 0.46 | ||||
USPH | US Physicalrapy | 0.39 | ||||
CCRN | Cross Country | 0.11 | ||||
DVA | DaVita HealthCare | 0.84 | ||||
EHAB | Enhabit | 1.27 | ||||
AGL | Agilon Health | 1.44 | ||||
ENSG | Ensign | 1.84 | ||||
SGRY | Surgery Partners | 2.61 | ||||
NHC | National HealthCare | 3.27 | ||||
PNTG | Pennant | 4.07 | ||||
INNV | InnovAge Holding | 4.27 |
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.